Innovative Designs for Clinical Trials of Cellular and Gene Therapy Products in Small Populations-2025/9/24

Computer Software Assurance for Production and Quality System Software-2025/9/24

Consideration of Enforcement Policies for In Vitro Diagnostic Tests During a Section 564 Declared Emergency-2025/9/23

Malaria: Developing Drugs for Treatment-2025/9/23

Safety Labeling Changes—Implementation of Section 505(o)(4) of the FD&C Act-2025/9/18

Erosive Esophagitis: Developing Drugs for Treatment-2025/9/17

Symptomatic Nonerosive Gastroesophageal Reflux Disease: Developing Drugs for Treatment-2025/9/17

Disseminated Coccidioidomycosis: Developing Drugs for Treatment-2025/9/17

Alternative Tools: Assessing Drug Manufacturing Facilities Identified in Pending Applications-2025/9/11

Development of Non-Opioid Analgesics for Chronic Pain-2025/9/10